Marcel Odaimi

515 total citations
33 papers, 391 citations indexed

About

Marcel Odaimi is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marcel Odaimi has authored 33 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Marcel Odaimi's work include Glioma Diagnosis and Treatment (7 papers), Brain Metastases and Treatment (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Marcel Odaimi is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Brain Metastases and Treatment (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Marcel Odaimi collaborates with scholars based in United States, India and Pakistan. Marcel Odaimi's co-authors include Ehud Arbit, Gilbert S. Lederman, Monika Wrzolek, Marek Wroński, Jaffer A. Ajani, Kenneth B. McCredie, Börje S. Andersson, Miloslav Beran, Susan C. Pannullo and Roberta L. Hayes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marcel Odaimi

30 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Odaimi United States 10 176 165 137 99 68 33 391
Ji Zhou China 16 225 1.3× 174 1.1× 292 2.1× 131 1.3× 129 1.9× 39 621
Claudia Tellez United States 9 121 0.7× 138 0.8× 256 1.9× 37 0.4× 35 0.5× 13 488
Lisa Hazard United States 12 82 0.5× 177 1.1× 188 1.4× 143 1.4× 41 0.6× 19 423
Tahir Latif United States 13 91 0.5× 108 0.7× 214 1.6× 74 0.7× 211 3.1× 38 588
Dae Ro Choi South Korea 14 58 0.3× 157 1.0× 167 1.2× 38 0.4× 98 1.4× 43 468
Isabelle Genvresse Germany 12 99 0.6× 105 0.6× 157 1.1× 16 0.2× 107 1.6× 27 472
P. Reinecke Germany 10 124 0.7× 76 0.5× 83 0.6× 29 0.3× 139 2.0× 35 418
Abhijeet Kumar United States 9 146 0.8× 78 0.5× 166 1.2× 22 0.2× 70 1.0× 38 352
Pablo Gajate Spain 15 72 0.4× 102 0.6× 329 2.4× 154 1.6× 146 2.1× 51 601
Marianne Rosamilia United States 5 309 1.8× 120 0.7× 119 0.9× 27 0.3× 163 2.4× 7 684

Countries citing papers authored by Marcel Odaimi

Since Specialization
Citations

This map shows the geographic impact of Marcel Odaimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Odaimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Odaimi more than expected).

Fields of papers citing papers by Marcel Odaimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Odaimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Odaimi. The network helps show where Marcel Odaimi may publish in the future.

Co-authorship network of co-authors of Marcel Odaimi

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Odaimi. A scholar is included among the top collaborators of Marcel Odaimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Odaimi. Marcel Odaimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Odaimi, Marcel, et al.. (2024). Aplastic anaemia associated with bendamustine therapy – a rare side effect. European Journal of Case Reports in Internal Medicine. 11(3). 4339–4339.
3.
Odaimi, Marcel, et al.. (2024). Hypercalcemia and Bone Metastasis in a Case of Large Cell Neuroendocrine Carcinoma With Unknown Primary. SHILAP Revista de lepidopterología. 2024. 1–6.
4.
Mustafa, Ahmad, et al.. (2024). Acute cardiovascular complications of disseminated intravascular coagulation in acute myeloid leukemia. Thrombosis Research. 239. 109042–109042. 3 indexed citations
5.
Ibrahim, Uroosa, et al.. (2018). Synchronous Pulmonary Neoplasms: A Chance Occurrence or is There More Than Meets the Eye?. Cureus. 10(2). e2162–e2162. 4 indexed citations
6.
Odaimi, Marcel, et al.. (2018). Renal Tubular Acidosis an Adverse Effect of PD-1 Inhibitor Immunotherapy. Case Reports in Oncological Medicine. 2018. 1–3. 26 indexed citations
7.
Ibrahim, Uroosa, et al.. (2018). Dasatinib-induced pulmonary arterial hypertension – A rare late complication. Journal of Oncology Pharmacy Practice. 25(3). 727–730. 4 indexed citations
8.
Odaimi, Marcel, et al.. (2017). Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review. Journal of Gastrointestinal Cancer. 48(2). 121–128. 34 indexed citations
9.
Ibrahim, Uroosa, et al.. (2016). Quiz Page September 2016. American Journal of Kidney Diseases. 68(3). A17–A20. 2 indexed citations
10.
Odaimi, Marcel, et al.. (2015). Bleomycin-induced flagellate erythema in a patient with Hodgkin’s lymphoma – A case report and review of literature. Journal of Oncology Pharmacy Practice. 22(3). 556–560. 13 indexed citations
11.
Wrzolek, Monika, et al.. (2010). A patient with multiple synchronous gliomas of distinctly different grades and correlative radiographic findings. Surgical Neurology International. 1(1). 48–48. 5 indexed citations
12.
Geara, Abdallah Sassine, et al.. (2009). Pseudoleukocytosis secondary to hepatitis C-associated cryoglobulinemia: a case report. Journal of Medical Case Reports. 3(1). 91–91. 3 indexed citations
13.
14.
Hayes, Roberta L., et al.. (2001). Adoptive cellular immunotherapy for the treatment of malignant gliomas. Critical Reviews in Oncology/Hematology. 39(1-2). 31–42. 45 indexed citations
15.
Lederman, Gilbert S., et al.. (2000). Treatment of Recurrent Glioblastoma Multiforme Using Fractionated Stereotactic Radiosurgery and Concurrent Paclitaxel. American Journal of Clinical Oncology. 23(2). 155–159. 97 indexed citations
16.
Lederman, Gilbert S., et al.. (1998). Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: A preliminary report. International Journal of Radiation Oncology*Biology*Physics. 40(3). 661–666. 37 indexed citations
17.
Lederman, Gilbert S., et al.. (1997). Recurrent Glioblastoma multiforme: Potential Benefits Using Fractionated Stereotactic Radiotherapy and Concurrent Taxol. Stereotactic and Functional Neurosurgery. 69(1-4). 162–174. 14 indexed citations
18.
Odaimi, Marcel, et al.. (1997). Improved survival using fractionated stereotactic radiosurgery (FSR) and concurrent taxol (T) for recurrent glioblastoma multiforme (RGM). European Journal of Cancer. 33. S202–S202. 1 indexed citations
19.
Odaimi, Marcel & Jaffer A. Ajani. (1986). Brain Metastases and Elevated α-Fetoprotein Level in a Patient With Esophageal Carcinoma. Southern Medical Journal. 79(10). 1304–1306. 5 indexed citations
20.
Odaimi, Marcel, Börje S. Andersson, Kenneth B. McCredie, & Miloslav Beran. (1986). Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.. PubMed. 46(7). 3330–3. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026